AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Amgen (AMGN) falls 3% after-hours following slight Q1 revenue miss
April 27, 2023 4:12 PM EDTAmgen (NASDAQ: AMGN) falls 3% after-hours following a slight Q1 revenue miss and so-so guidance:
Amgen reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.Amgen sees Q2... MoreAmgen (AMGN) Tops Q1 EPS by 16c
April 27, 2023 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.
GUIDANCE:
Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY... More
